Article
CDK1 inhibition sensitizes normal cells to DNA damage in a cell cycle dependent manner
18 Jun 2018
Abstract excerpt
Cyclin-dependent kinase 1 (CDK1) orchestrates the transition from the G2 phase into mitosis and as cancer cells often display enhanced CDK1 activity, it has been proposed as a tumor specific anti-cancer target. Here we show that the effects of CDK1 inhibition are not restricted to tumor cells but can also reduce viability in non-cancer cells and sensitize them to radiation in a cell cycle dependent manner....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
